These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19769931)

  • 21. Investigation of the complexation of albendazole with cyclodextrins for the design of new antiparasitic formulations.
    Pradines B; Gallard JF; Iorga BI; Gueutin C; Loiseau PM; Ponchel G; Bouchemal K
    Carbohydr Res; 2014 Oct; 398():50-5. PubMed ID: 25240182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A benzimidazole derivative (RCB20) in vitro induces an activation of energetic pathways on Taenia crassiceps (ORF strain) cysticerci.
    Fraga CM; da Costa TL; de Castro AM; Reynoso-Ducoing O; Ambrosio J; Hernández-Campos A; Castillo R; Vinaud MC
    Exp Parasitol; 2017 Jan; 172():12-17. PubMed ID: 27884580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy.
    Ammar HO; Salama HA; Ghorab M; Mahmoud AA
    Int J Pharm; 2006 Aug; 320(1-2):53-7. PubMed ID: 16701974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Murine cysticercosis model: influence of the infection time and the time of treatment on the cysticidal efficacy of albendazole and praziquantel.
    Palomares-Alonso F; Palencia Hernández G; Rojas-Tomé IS; Jung-Cook H; Pinzón-Estrada E
    Exp Parasitol; 2015 Feb; 149():1-6. PubMed ID: 25500213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo albendazole treatment of Taenia crassiceps cysticerci strain WFU: proliferation, damage, and recovery.
    Zurabian R; Aguilar-Vega L; Terrones Vargas E; Cervera Hernández ME; Willms K; Ruíz-Velasco Acosta S
    Parasitol Res; 2013 Nov; 112(11):3961-8. PubMed ID: 24005476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2-Hydroxypropyl-beta-cyclodextrin improves the effectiveness of albendazole against encapsulated larvae of Trichinella spiralis in a murine model.
    Casulli A; Morales MA; Gallinella B; Turchetto L; Pozio E
    J Antimicrob Chemother; 2006 Oct; 58(4):886-90. PubMed ID: 16895937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solid-state characterization and dissolution properties of naproxen-arginine-hydroxypropyl-beta-cyclodextrin ternary system.
    Mura P; Bettinetti GP; Cirri M; Maestrelli F; Sorrenti M; Catenacci L
    Eur J Pharm Biopharm; 2005 Jan; 59(1):99-106. PubMed ID: 15567306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin.
    Nair AB; Attimarad M; Al-Dhubiab BE; Wadhwa J; Harsha S; Ahmed M
    Drug Deliv; 2014 Nov; 21(7):540-7. PubMed ID: 24215288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spray drying formulation of albendazole microspheres by experimental design. In vitro-in vivo studies.
    García A; Leonardi D; Piccirilli GN; Mamprin ME; Olivieri AC; Lamas MC
    Drug Dev Ind Pharm; 2015 Feb; 41(2):244-52. PubMed ID: 24237328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repositioning of Anti-parasitic Drugs in Cyclodextrin Inclusion Complexes for Treatment of Triple-Negative Breast Cancer.
    Priotti J; Baglioni MV; García A; Rico MJ; Leonardi D; Lamas MC; Menacho Márquez M
    AAPS PharmSciTech; 2018 Nov; 19(8):3734-3741. PubMed ID: 30255471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of albendazole against Taenia multiceps larvae in experimentally infected goats.
    Afonso SM; Neves L; Pondja A; Macuamule C; Mukaratirwa S; Arboix M; Cristòfol C; Capece BP
    Vet Parasitol; 2014 Dec; 206(3-4):304-7. PubMed ID: 25450723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increasing the solubility characteristics of albendazole with dimethyl-beta-cyclodextrin.
    Kata M; Schauer M
    Acta Pharm Hung; 1991 Jan; 61(1):23-31. PubMed ID: 1872189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of New Benzimidazole Derivatives as Cysticidal Agents: In Vitro, in Vivo and Docking Studies.
    González-Hernández I; Palomares-Alonso F; Becerril-Vega J; Melchor-Doncel de la Torre S; Hernández-Luis F; Rodriguez-Morales S; Aguayo-Ortiz R; Dominguez L; Rodríguez-Balderas CA; González-Maciel A; Rojas-Tomé IS; Castro N; Jung-Cook H
    Chem Pharm Bull (Tokyo); 2019; 67(12):1293-1300. PubMed ID: 31787656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Historic of therapeutic efficacy of albendazol sulphoxide administered in different routes, dosages and treatment schemes, against Taenia saginata cysticercus in cattle experimentally infected.
    Lopes WD; Cruz BC; Soares VE; Nunes JL; Teixeira WF; Maciel WG; Buzzulini C; Pereira JC; Felippelli G; Soccol VT; de Oliveira GP; da Costa AJ
    Exp Parasitol; 2014 Feb; 137():14-20. PubMed ID: 24309372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole.
    Taupitz T; Dressman JB; Buchanan CM; Klein S
    Eur J Pharm Biopharm; 2013 Apr; 83(3):378-87. PubMed ID: 23201048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo evaluation of the efficacy of albendazole sulfoxide and albendazole sulfoxide loaded solid lipid nanoparticles against hydatid cyst.
    Ahmadnia S; Moazeni M; Mohammadi-Samani S; Oryan A
    Exp Parasitol; 2013 Oct; 135(2):314-9. PubMed ID: 23912040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A benzimidazole derivative (RCB15) in vitro induces the alternative energetic metabolism and glycolysis in Taenia crassiceps cysticerci.
    de Andrade Picanço G; de Lima NF; Fraga CM; da Costa TL; Isac E; Ambrosio J; Castillo R; Vinaud MC
    Acta Trop; 2017 Dec; 176():288-292. PubMed ID: 28865900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Could ivermectin have a synergic effect with albendazole in hydatidosis therapy?
    Moreno MJ; Casado N; Urrea-París MA; Rodríguez-Caabeiro F
    Parasitol Res; 2002 Jun; 88(6):563-7. PubMed ID: 12107480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the bioavailability of flurbiprofen and its beta-cyclodextrin inclusion complex in four different doses upon oral administration to rats.
    Muraoka A; Tokumura T; Machida Y
    Eur J Pharm Biopharm; 2004 Nov; 58(3):667-71. PubMed ID: 15451543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of dissolution amount and in vivo bioavailability of itraconazole by complexation with beta-cyclodextrin using supercritical carbon dioxide.
    Hassan HA; Al-Marzouqi AH; Jobe B; Hamza AA; Ramadan GA
    J Pharm Biomed Anal; 2007 Oct; 45(2):243-50. PubMed ID: 17630246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.